Observations show high CNS polypharmacy rates in nursing homes, indicating a need for deprescribing strategies and nonpharmacologic interventions.
CNS polypharmacy was common in US nursing homes, especially among residents with psychiatric comorbidity and in pain. These findings underscore the need for deprescribing strategies and nonpharmacologic interventions to mitigate risks associated with CNS polypharmacy.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: